Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TASHA: Anticoagulation Strategies for Hemodialysis in Patients at Risk of Hemorrhage
NCT03419923Unknown
- Sponsor
- Guangdong Provincial People's Hospital
- Start
- Sep 2017
- Primary completion
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of trisodium citrate in end stage renal disease (ESRD) (3 arms), sponsored by Guangdong Provincial People's Hospital. Primary endpoint: therapy interruption event at 4 hours. Status: unknown.
02
Drugs
trisodium citrate
03
Conditions
end stage renal disease (ESRD)
Beyond the preview
Go deeper on NCT03419923.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03419923.